Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lucinactant in pediatric acute hypoxemic respiratory failure
NCT00578734Phase 2Completed
- Sponsor
- Windtree Therapeutics, Inc.
- Start
- Jun 2007
- Primary completion
- Apr 2010
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 2
01
Overview
A Phase 2 trial of lucinactant in acute hypoxemic respiratory failure (AHRF), sponsored by Windtree Therapeutics, Inc.. Started Jun 2007; status: completed.
02
Drugs
lucinactant
03
Conditions
acute hypoxemic respiratory failure (AHRF)
Beyond the preview
Go deeper on NCT00578734.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00578734.